Compare CPIX & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CPIX | GROW |
|---|---|---|
| Founded | 1999 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.1M | 32.2M |
| IPO Year | 2009 | N/A |
| Metric | CPIX | GROW |
|---|---|---|
| Price | $3.91 | $2.36 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 173.2K | 43.8K |
| Earning Date | 11-04-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 3.75% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | ★ $41,278,349.00 | $8,546,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $36.81 |
| Revenue Growth | ★ 12.21 | N/A |
| 52 Week Low | $1.85 | $2.02 |
| 52 Week High | $7.25 | $2.78 |
| Indicator | CPIX | GROW |
|---|---|---|
| Relative Strength Index (RSI) | 80.29 | 46.23 |
| Support Level | $2.42 | $2.36 |
| Resistance Level | $2.73 | $2.50 |
| Average True Range (ATR) | 0.34 | 0.07 |
| MACD | 0.20 | -0.00 |
| Stochastic Oscillator | 91.45 | 27.97 |
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.